Literature DB >> 19843245

TYRO3-mediated regulation of MITF: a novel target in melanoma?

Udo Rudloff, Yardena Samuels.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19843245      PMCID： PMC3159175          DOI： 10.1111/j.1755-148X.2009.00649.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN： 1755-1471            Impact factor:   4.693


× No keyword cloud information.
  7 in total

1.  A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control.

Authors:  Vadim Budagian; Elena Bulanova; Zane Orinska; Lutz Thon; Uwe Mamat; Paola Bellosta; Claudio Basilico; Dieter Adam; Ralf Paus; Silvia Bulfone-Paus
Journal:  EMBO J       Date:  2005-11-24       Impact factor: 11.598

2.  Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.

Authors:  Levi A Garraway; Hans R Widlund; Mark A Rubin; Gad Getz; Aaron J Berger; Sridhar Ramaswamy; Rameen Beroukhim; Danny A Milner; Scott R Granter; Jinyan Du; Charles Lee; Stephan N Wagner; Cheng Li; Todd R Golub; David L Rimm; Matthew L Meyerson; David E Fisher; William R Sellers
Journal:  Nature       Date:  2005-07-07       Impact factor: 49.962

3.  A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors.

Authors:  D Mahadevan; L Cooke; C Riley; R Swart; B Simons; K Della Croce; L Wisner; M Iorio; K Shakalya; H Garewal; R Nagle; D Bearss
Journal:  Oncogene       Date:  2007-02-26       Impact factor: 9.867

4.  Pharmacologic suppression of MITF expression via HDAC inhibitors in the melanocyte lineage.

Authors:  Satoru Yokoyama; Erez Feige; Laura L Poling; Carmit Levy; Hans R Widlund; Mehdi Khaled; Andrew L Kung; David E Fisher
Journal:  Pigment Cell Melanoma Res       Date:  2008-06-27       Impact factor: 4.693

5.  Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial.

Authors:  Alexander M M Eggermont; Stefan Suciu; Mario Santinami; Alessandro Testori; Wim H J Kruit; Jeremy Marsden; Cornelis J A Punt; François Salès; Martin Gore; Rona Mackie; Zvonko Kusic; Reinhard Dummer; Axel Hauschild; Elena Musat; Alain Spatz; Ulrich Keilholz
Journal:  Lancet       Date:  2008-07-12       Impact factor: 79.321

6.  Frequent mutations in the MITF pathway in melanoma.

Authors:  Julia C Cronin; John Wunderlich; Stacie K Loftus; Todd D Prickett; Xiaomu Wei; Katie Ridd; Swapna Vemula; Allison S Burrell; Neena S Agrawal; Jimmy C Lin; Carolyn E Banister; Phillip Buckhaults; Steven A Rosenberg; Boris C Bastian; William J Pavan; Yardena Samuels
Journal:  Pigment Cell Melanoma Res       Date:  2009-04-29       Impact factor: 4.693

Review 7.  Transcriptional regulation in melanoma.

Authors:  Devarati Mitra; David E Fisher
Journal:  Hematol Oncol Clin North Am       Date:  2009-06       Impact factor: 3.722
  7 in total
  1 in total

1.  Evaluation of antioxidant and anti-melanogenic activities of different extracts from aerial parts of Nepeta binaludensis Jamzad in murine melanoma B16F10 cells.

Authors:  Zahra Tayarani-Najaran; Maryam Akaberi; Mohsen Vatani; Seyed Ahmad Emami
Journal:  Iran J Basic Med Sci       Date:  2016-06       Impact factor: 2.699
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.